XML 19 R8.htm IDEA: XBRL DOCUMENT v3.22.2
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 9 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Cash flows from operating activities:    
Net income before noncontrolling interest $ 135,247 $ 129,026
Adjustments to reconcile net income to net cash provided by (used in) operating activities:    
Depreciation, amortization and accretion, net 47,193 43,561
Provision for credit losses 31,186 40,991
Provision (reversal of) for deferred taxes 18,517 (1,360)
Originations of loans held for sale (769,672) (472,935)
Proceeds from sales of loans held for sale 898,442 694,063
Net change in loans held for sale 12,568 2,495
Fair value adjustment of foreclosed real estate 250 481
Net realized (gain) on securities available for sale, net (161) (6)
Net realized (gain) loss on loans held for sale 3,933 (9,804)
Net realized loss on premise, furniture, and equipment 45 0
Net realized (gain) on lease receivables and equipment (2,180) (1,076)
Net realized (gain) on foreclosed real estate and repossessed assets 0 (4)
Net realized (gain) on trademarks (50,000) 0
Net realized (gain) loss on other assets (434) 28
Change in bank-owned life insurance value (1,818) (1,827)
Impairment of intangibles 670 0
Net change in accrued interest receivable (564) 398
Net change in other assets (7,391) (3,742)
Net change in accrued expenses and other liabilities (36,577) 25,332
Stock compensation 7,765 5,090
Net cash provided by operating activities 287,019 450,711
Cash flows from investing activities:    
Purchases of securities available for sale (689,515) (976,502)
Proceeds from sales of securities available for sale 244,305 50,468
Proceeds from maturities of and principal collected on securities available for sale 264,808 266,673
Proceeds from maturities of and principal collected on securities held to maturity 12,189 27,041
Purchases of Federal Reserve Bank and Federal Home Loan Bank stock (134,293) (1,295)
Redemption of Federal Reserve Bank and Federal Home Loan Bank stock 133,880 0
Purchases of loans and leases (108,570) (145,639)
Proceeds from sales of loans and leases 45,784 13,822
Net change in loans and leases 35,462 (177,944)
Purchases of premises, furniture, and equipment (5,860) (9,448)
Proceeds from sales of premises, furniture, and equipment 35 86
Purchases of rental equipment (270,262) (36,800)
Proceeds from sales of rental equipment 8,236 11,744
Net change in rental equipment (1,879) (2,303)
Proceeds from sales of foreclosed real estate and repossessed assets 1,814 8,285
Proceeds from sale of trademarks 50,000 0
Proceeds from sale of other assets 2,925 0
Net cash (used in) investing activities (410,941) (971,812)
Cash flows from financing activities:    
Net change in deposits 195,828 909,672
Redemption of long-term borrowings (75,000) 0
Principal payments on capital lease obligations (75) (24)
Principal payments on other liabilities (2,163) (4,775)
Proceeds from other liabilities 0 80
Dividends paid on common stock (4,469) (4,804)
Issuance of common stock due to restricted stock 1 0
Issuance of common stock due to ESOP 2,886 3,036
Repurchases of common stock (146,763) (87,018)
Distributions to noncontrolling interest (2,771) (2,882)
Net cash (used in) financing activities (32,526) 813,285
Effect of exchange rate changes on cash (311) 692
Net change in cash and cash equivalents (156,759) 292,876
Cash and cash equivalents at beginning of fiscal year 314,019 427,367
Cash and cash equivalents at end of fiscal period 157,260 720,243
Supplemental disclosure of cash flow information:    
Interest 4,779 5,544
Income taxes 10,898 4,147
Franchise taxes 200 200
Other taxes 516 671
Supplemental schedule of non-cash investing activities:    
Trade Date Purchases - AFS 101,993 0
Held for sale to loans and leases 14,731 0
Loans and leases to held for sale 169,045 118,037
Loans and leases to rental equipment 3,393 14,844
Loans and leases to foreclosed real estate and repossessed assets 0 9
Rental equipment to loan and leases 233,634 14,014
Recognition of operating lease ROU assets, net of measurements $ 389 $ 12,954